Skip to main content
Premium Trial:

Request an Annual Quote

Court Orders Mediation Conference in Helicos Patent Suit Against PacBio, Life Tech, Illumina

Premium

By Julia Karow

A magistrate judge has ordered a mediation conference next month between Helicos Biosciences and three companies it is suing for patent infringement: Pacific Biosciences, Life Technologies, and Illumina.

Helicos filed the suit against PacBio a year ago in the US District Court for the District of Delaware, claiming that PacBio's sequencing technology infringes four of its patents. It later added Illumina and Life Technologies as defendants to the suit. In response, all three defendants countersued Helicos, claiming that several of the patents are invalid and unenforceable (IS 12/21/2010).

In a separate but related action, the United States Patent and Trademark Office recently rejected the claims of the four Helicos patents in a non-final office action after granting a reexamination request from PacBio (IS 5/10/2011).

Earlier this month, a magistrate judge ordered a mediation conference in the case for Aug. 29 and 30, during which Helicos will meet individually with the three defendants.

Each party needs to submit a mediation statement to the judge by Aug. 19, which will not become part of the court record. In these statements, the parties are asked to provide factual background, a summary of the law, an "honest discussion" of the strengths and weaknesses of their claims and defenses, a description of prior settlement negotiations and discussions, proposed terms for a resolution of the case, and an estimate of costs.

The contents of the mediation statements and the mediation conference discussions, including any resolution or settlement, will remain confidential.

The court said it "encourages all participants to keep an open mind in order to reassess their previous positions and to find creative means for resolving the dispute."


Have topics you'd like to see covered in In Sequence? Contact the editor at jkarow [at] genomeweb [.] com.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.